ResoTher Pharma

About:

ResoTher Pharma is a privately held biotechnology company

Website: https://resotherpharma.com/

Top Investors: European Innovation Council, EIC Accelerator, M Ventures, CAPNOVA

Description:

ResoTher Pharma is a privately held biotechnology company located in Copenhagen, Denmark. The company is focused on developing peptide-based drugs derived from the endogenous immunomodulator Annexin A1 as resolution therapy for diseases where neutrophil-driven inflammation plays a key pathological role. Their current focus is on cardiovascular disorders and inflammatory disorders with a large unmet medical need.

Total Funding Amount:

$5.05M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Holte, Syddanmark, Denmark

Founded Date:

2016-01-01

Contact Email:

lone.veng(AT)resotherpharma.com

Founders:

Jeppe Ovli Ovlesen

Number of Employees:

1-10

Last Funding Date:

2023-11-06

IPO Status:

Private

Industries:

© 2025 bioDAO.ai